Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Long-term outcome of children with pediatric-onset cutaneous and visceral polyarteritis nodosa.

Merlin E, Mouy R, Pereira B, Mouthon L, Bourmaud A, Piette JC, Landman-Parker J, Chellun P, Layadi M, Thomas C, Guillevin L, Prieur AM, Quartier P.

Joint Bone Spine. 2015 Jul;82(4):251-7. doi: 10.1016/j.jbspin.2015.01.007. Epub 2015 Apr 15.

PMID:
25887252
2.

Effect of biologic treatments on growth in children with juvenile idiopathic arthritis.

Uettwiller F, Perlbarg J, Pinto G, Bader-Meunier B, Mouy R, Compeyrot-Lacassagne S, Melki I, Wouters C, Prieur AM, Landais P, Polak M, Quartier P.

J Rheumatol. 2014 Jan;41(1):128-35. doi: 10.3899/jrheum.130311. Epub 2013 Dec 1.

PMID:
24293576
3.

ANCA-associated glomerulonephritis in systemic-onset juvenile idiopathic arthritis.

Belot A, Bader-Meunier B, Niaudet P, Salomon R, Prieur AM, Noel LH, Quartier P.

Am J Kidney Dis. 2012 Mar;59(3):439-43. doi: 10.1053/j.ajkd.2011.11.002. Epub 2011 Dec 20.

PMID:
22189036
4.

Cataract surgery with primary intraocular lens implantation in children with uveitis: long-term outcomes.

Terrada C, Julian K, Cassoux N, Prieur AM, Debre M, Quartier P, LeHoang P, Bodaghi B.

J Cataract Refract Surg. 2011 Nov;37(11):1977-83. doi: 10.1016/j.jcrs.2011.05.037. Epub 2011 Sep 22.

PMID:
21940141
5.

Mevalonate kinase deficiency: a survey of 50 patients.

Bader-Meunier B, Florkin B, Sibilia J, Acquaviva C, Hachulla E, Grateau G, Richer O, Farber CM, Fischbach M, Hentgen V, Jego P, Laroche C, Neven B, Lequerré T, Mathian A, Pellier I, Touitou I, Rabier D, Prieur AM, Cuisset L, Quartier P; SOFREMIP (Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie); CRI (Club Rhumatismes et Inflammations).

Pediatrics. 2011 Jul;128(1):e152-9. doi: 10.1542/peds.2010-3639. Epub 2011 Jun 27.

PMID:
21708801
6.

Ocular modifications in a young girl with cryopyrin-associated periodic syndromes responding to interleukin-1 receptor antagonist anakinra.

Terrada C, Neven B, Boddaert N, Souied EH, Prieur AM, Quartier P, Lehoang P, Bodaghi B.

J Ophthalmic Inflamm Infect. 2011 Sep;1(3):133-6. doi: 10.1007/s12348-010-0018-2. Epub 2011 Apr 9.

7.

Sicca syndrome and salivary gland infiltration in children with autoimmune disorders: when can we diagnose Sjögren syndrome?

Schuetz C, Prieur AM, Quartier P.

Clin Exp Rheumatol. 2010 May-Jun;28(3):434-9. Epub 2010 Jun 23.

PMID:
20576229
8.

Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.

Neven B, Marvillet I, Terrada C, Ferster A, Boddaert N, Couloignier V, Pinto G, Pagnier A, Bodemer C, Bodaghi B, Tardieu M, Prieur AM, Quartier P.

Arthritis Rheum. 2010 Jan;62(1):258-67. doi: 10.1002/art.25057.

9.

Ocular threat in juvenile idiopathic arthritis.

Marvillet I, Terrada C, Quartier P, Quoc EB, Bodaghi B, Prieur AM.

Joint Bone Spine. 2009 Jul;76(4):383-8. doi: 10.1016/j.jbspin.2008.10.015. Epub 2009 Jun 12.

PMID:
19524473
10.

Cryopyrinopathies: update on pathogenesis and treatment.

Neven B, Prieur AM, Quartier dit Maire P.

Nat Clin Pract Rheumatol. 2008 Sep;4(9):481-9. doi: 10.1038/ncprheum0874. Epub 2008 Jul 29. Review.

PMID:
18665151
11.

Comparative tolerability of treatments for juvenile idiopathic arthritis.

Prieur AM, Quartier P.

BioDrugs. 2000 Sep;14(3):159-83.

PMID:
18034568
12.

Mevalonate kinase deficiency syndrome with structural damage responsive to anakinra.

Lequerré T, Vittecoq O, Pouplin S, Klemmer N, Mejjad O, Daragon A, Prieur AM, Le Loët X.

Rheumatology (Oxford). 2007 Dec;46(12):1860-2. Epub 2007 Oct 25. No abstract available.

PMID:
17965046
13.

A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis.

Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann RK, Gamir ML, Wulffraat N, Marodi L, Petty RE, Joos R, Zulian F, McCurdy D, Myones BL, Nagy K, Reuman P, Szer I, Travers S, Beutler A, Keenan G, Clark J, Visvanathan S, Fasanmade A, Raychaudhuri A, Mendelsohn A, Martini A, Giannini EH; Paediatric Rheumatology International Trials Organisation; Pediatric Rheumatology Collaborative Study Group.

Arthritis Rheum. 2007 Sep;56(9):3096-106.

14.

[Juvenile idiopathic arthritis. II. Treatment and prognosis].

Quartier P, Prieur AM.

Rev Prat. 2007 Jun 30;57(12):1289-93. Review. French.

PMID:
17717939
15.

[Juvenile idiopathic arthritis. (I) Clinical aspects].

Quartier P, Prieur AM.

Rev Prat. 2007 Jun 15;57(11):1171-8. Review. French.

PMID:
17691258
16.

Allogeneic bone marrow transplantation in mevalonic aciduria.

Neven B, Valayannopoulos V, Quartier P, Blanche S, Prieur AM, Debré M, Rolland MO, Rabier D, Cuisset L, Cavazzana-Calvo M, de Lonlay P, Fischer A.

N Engl J Med. 2007 Jun 28;356(26):2700-3.

17.

Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study.

Simon D, Prieur AM, Quartier P, Charles Ruiz J, Czernichow P.

J Clin Endocrinol Metab. 2007 Jul;92(7):2567-73. Epub 2007 May 8.

PMID:
17488793
18.

[Transition care in pediatric rheumatology].

Prieur AM, Deslandre C, Lemelle I.

Arch Pediatr. 2007 Jun;14(6):665-7. Epub 2007 Apr 6. French. No abstract available.

PMID:
17419034
19.

Proxy-reported health-related quality of life of patients with juvenile idiopathic arthritis: the Pediatric Rheumatology International Trials Organization multinational quality of life cohort study.

Oliveira S, Ravelli A, Pistorio A, Castell E, Malattia C, Prieur AM, Saad-Magalhães C, Murray KJ, Bae SC, Joos R, Foeldvari I, Duarte-Salazar C, Wulffraat N, Lahdenne P, Dolezalova P, de Inocencio J, Kanakoudi-Tsakalidou F, Hofer M, Nikishina I, Ozdogan H, Hashkes PJ, Landgraf JM, Martini A, Ruperto N; Pediatric Rheumatology International Trials Organization (PRINTO).

Arthritis Rheum. 2007 Feb 15;57(1):35-43.

20.

A child with a systemic febrile illness - differential diagnosis and management.

Hofer M, Mahlaoui N, Prieur AM.

Best Pract Res Clin Rheumatol. 2006 Aug;20(4):627-40. Review.

PMID:
16979528
21.

EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides.

Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, Prieur AM, Ravelli A, Woo P.

Ann Rheum Dis. 2006 Jul;65(7):936-41. Epub 2005 Dec 1.

23.

Improvements in growth parameters in children with juvenile idiopathic arthritis associated with the effect of methotrexate on disease activity.

Chédeville G, Quartier P, Miranda M, Brauner R, Prieur AM.

Joint Bone Spine. 2005 Oct;72(5):392-6. Epub 2005 Jun 23.

PMID:
16087383
24.

Camptodactyly-arthropathy-coxa vara-pericarditis syndrome versus juvenile idiopathic arthropathy.

Offiah AC, Woo P, Prieur AM, Hasson N, Hall CM.

AJR Am J Roentgenol. 2005 Aug;185(2):522-9.

PMID:
16037531
25.

Cementless hip arthroplasty in juvenile idiopathic arthritis.

Odent T, Journeau P, Prieur AM, Touzet P, Pouliquen JC, Glorion C.

J Pediatr Orthop. 2005 Jul-Aug;25(4):465-70.

PMID:
15958896
26.

Chronic infantile neurological, cutaneous, and articular syndrome with severe early articular manifestations.

Leys C, Eschard C, Motte J, Prieur AM, Kalis B, Bernard P.

Pediatr Dermatol. 2005 May-Jun;22(3):222-6.

PMID:
15916569
27.

Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study.

Bader-Meunier B, Armengaud JB, Haddad E, Salomon R, Deschênes G, Koné-Paut I, Leblanc T, Loirat C, Niaudet P, Piette JC, Prieur AM, Quartier P, Bouissou F, Foulard M, Leverger G, Lemelle I, Pilet P, Rodière M, Sirvent N, Cochat P.

J Pediatr. 2005 May;146(5):648-53.

PMID:
15870669
28.

PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it.

Ruperto N, Garcia-Munitis P, Villa L, Pesce M, Aggarwal A, Fasth A, Avcin T, Bae SC, Balogh Z, Li C, De Inocencio J, Dibra M, Dolezalova P, El Miedany Y, Flato B, Harjacek M, Huppertz HI, Kanakoudi-Tsakalidou F, Wulffraat N, Lahdenne P, Melo-Gomes JA, Mihaylova D, Nielsen S, Nikishina I, Ozdogan H, Pagava K, Panaviene V, Prieur AM, Romicka AM, Rumba I, Shafaie N, Susic G, Takei S, Uziel Y, Vesely R, Woo P, Martini A; Paediatric Rheumatology International Trials Organisation; Paediatric Rheumatology European Society.

Ann Rheum Dis. 2005 Jul;64(7):1101-6. Epub 2005 Mar 10.

29.

A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.

Ruperto N, Nikishina I, Pachanov ED, Shachbazian Y, Prieur AM, Mouy R, Joos R, Zulian F, Schwarz R, Artamonova V, Emminger W, Bandeira M, Buoncompagni A, Foeldvari I, Falcini F, Baildam E, Kone-Paut I, Alessio M, Gerloni V, Lenhardt A, Martini A, Hanft G, Sigmund R, Simianer S; Pediatric Rheumatology International Trials Organization.

Arthritis Rheum. 2005 Feb;52(2):563-72.

30.

Systemic juvenile idiopathic arthritis presenting in a young child with long term disability as an adolescent.

Bailey KM, McDonagh JE, Prieur AM.

Ann Rheum Dis. 2004 Dec;63(12):1544-8. Review. No abstract available.

31.

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.

Holzelova E, Vonarbourg C, Stolzenberg MC, Arkwright PD, Selz F, Prieur AM, Blanche S, Bartunkova J, Vilmer E, Fischer A, Le Deist F, Rieux-Laucat F.

N Engl J Med. 2004 Sep 30;351(14):1409-18.

32.

[The presentation of childhood systemic lupus erythematosus with neurological symptoms: three-case reports].

Chanzy S, Routon MC, Prieur AM, Larroche C, Mselati JC.

Rev Neurol (Paris). 2004 Sep;160(8-9):817-20. French.

PMID:
15454868
33.

Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity.

De Kleer IM, Brinkman DM, Ferster A, Abinun M, Quartier P, Van Der Net J, Ten Cate R, Wedderburn LR, Horneff G, Oppermann J, Zintl F, Foster HE, Prieur AM, Fasth A, Van Rossum MA, Kuis W, Wulffraat NM.

Ann Rheum Dis. 2004 Oct;63(10):1318-26.

34.

[Disseminated lupus erythematosus in children: guidelines about investigations during the initial evaluation and follow-up].

Bader-Meunier B, Haddad E, Niaudet P, Loirat C, Leblanc T, Amoura Z, Bodemer C, Cochat P, Deschênes G, Koné-Paut I, Lévy M, Prieur AM, Quartier P, Ranchin B, Salomon R, Piette JC; Groupe d'étude du lupus érythémateux systémique à début pédiatrique.

Arch Pediatr. 2004 Aug;11(8):941-4. French.

PMID:
15288087
35.

Development of Crohn disease during anti-TNF-alpha therapy in a child with juvenile idiopathic arthritis.

Ruemmele FM, Prieur AM, Talbotec C, Goulet O, Schmitz J.

J Pediatr Gastroenterol Nutr. 2004 Aug;39(2):203-6. No abstract available.

PMID:
15269630
36.

Clostridium difficile-associated reactive arthritis in two children.

Löffler HA, Pron B, Mouy R, Wulffraat NM, Prieur AM.

Joint Bone Spine. 2004 Jan;71(1):60-2.

PMID:
14769523
37.

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P; International League of Associations for Rheumatology.

J Rheumatol. 2004 Feb;31(2):390-2. No abstract available.

PMID:
14760812
38.

Effects on growth and body composition of growth hormone treatment in children with juvenile idiopathic arthritis requiring steroid therapy.

Simon D, Lucidarme N, Prieur AM, Ruiz JC, Czernichow P.

J Rheumatol. 2003 Nov;30(11):2492-9.

PMID:
14677197
39.

Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU.

Neven B, Callebaut I, Prieur AM, Feldmann J, Bodemer C, Lepore L, Derfalvi B, Benjaponpitak S, Vesely R, Sauvain MJ, Oertle S, Allen R, Morgan G, Borkhardt A, Hill C, Gardner-Medwin J, Fischer A, de Saint Basile G.

Blood. 2004 Apr 1;103(7):2809-15. Epub 2003 Nov 20.

PMID:
14630794
40.

The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families.

Ogilvie EM, Fife MS, Thompson SD, Twine N, Tsoras M, Moroldo M, Fisher SA, Lewis CM, Prieur AM, Glass DN, Woo P.

Arthritis Rheum. 2003 Nov;48(11):3202-6.

41.

[Prolonged fever of unknown origin: the point of view of the rheumatologist].

Prieur AM.

Arch Pediatr. 2003 May;10 Suppl 1:193s-194s. French. No abstract available.

PMID:
14509795
42.

Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis.

Wulffraat NM, Brinkman D, Ferster A, Opperman J, ten Cate R, Wedderburn L, Foster H, Abinun M, Prieur AM, Horneff G, Zintl F, de Kleer I, Kuis W.

Bone Marrow Transplant. 2003 Aug;32 Suppl 1:S61-4.

PMID:
12931245
43.

[Contribution of recent physiopathogenic progresses to the diagnosis of recurrent fevers].

Koné-Paut I, Bouayed K, Prieur AM.

Arch Pediatr. 2003 Aug;10(8):719-26. Review. French.

PMID:
12922007
44.

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.

Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, Garay S, Kuis W, Machado C, Pachman L, Prieur AM, Rider LG, Silverman E, Tsitsami E, Woo P, Giannini EH, Martini A; Paediatric Rheumatology International Trials Organization (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG).

Rheumatology (Oxford). 2003 Dec;42(12):1452-9. Epub 2003 Jun 27. Review.

PMID:
12832713
45.

[Childhood-onset systemic lupus erythematosus].

Bader-Meunier B, Quartier P, Deschênes G, Cochat P, Haddad E, Koné-Paut I, Leblanc T, Prieur AM, Salomon R, Bodemer C, Lévy M; Group française d'étude du lupus érythémateux disséminé de l'enfant.

Arch Pediatr. 2003 Feb;10(2):147-57. Review. French.

PMID:
12829358
46.

[Systemic lupus erythematosus].

Quartier P, Prieur AM.

Arch Pediatr. 2003 Apr;10(4):367-73. French. No abstract available.

PMID:
12818767
47.

Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.

Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, Sibilia J, Koné-Paut I, Gandon-Laloum S, LeBideau M, Bader-Meunier B, Mouy R, Debré M, Landais P, Prieur AM.

Arthritis Rheum. 2003 Apr;48(4):1093-101.

48.

Validation of the French version of the Childhood Health Assessment Questionnaire (CHAQ) in juvenile idiopathic arthritis.

Pouchot J, Larbre JP, Lemelle I, Sommelet D, Grouteau E, David L, Duquesne A, Deslandre CJ, Koné Paut I, Pillet P, Goumy L, Barbier C, Guyot MH, Mazingue F, Laloum SG, Fischbac M, Quartier P, Guyot C, Jean S, Legall E, Plouvier E, Bost M, de Lumley L, Brégeon C, Guillemin F, Coste J, Prieur AM; Pediatric Rheumatology Interational Trials Organisation Qualité de Vie en Rhumatologie Group.

Joint Bone Spine. 2002 Oct;69(5):468-81.

PMID:
12477231
49.

Immunodeficiency and genetic conditions that cause arthritis in childhood.

Quartier P, Prieur AM.

Curr Rheumatol Rep. 2002 Dec;4(6):483-93. Review.

PMID:
12427362
50.

Treatment of growth failure in juvenile chronic arthritis.

Simon D, Lucidarme N, Prieur AM, Ruiz JC, Czernichow P.

Horm Res. 2002;58 Suppl 1:28-32. Review.

PMID:
12373011

Supplemental Content

Loading ...
Support Center